{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:22:16Z","timestamp":1780348936133,"version":"3.54.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/mjt.0b013e3181d070d7","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T08:15:25Z","timestamp":1269418525000},"page":"292-299","source":"Crossref","is-referenced-by-count":26,"title":["A Study of Abrupt Phentermine Cessation in Patients in a Weight Management Program"],"prefix":"10.1097","volume":"18","author":[{"given":"Ed J","family":"Hendricks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L","family":"Greenway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210202","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jama.1937.02780070012004","article-title":"The central action of beta-aminopropylbenzine (Benzadrine) clinical observations.","volume":"108","author":"Nathanson","year":"1937","journal-title":"J Am Med Assoc"},{"key":"R2-5-20210202","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM193710282171804","article-title":"Narcolepsy and its treatment with Benzedrine sulfate.","volume":"217","author":"Ulrich","year":"1937","journal-title":"N Engl J Med"},{"key":"R3-5-20210202","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJM193801202180307","article-title":"Human autonomic pharmacology XVI. Benzedrine sulfate as an aid in the treatment of obesity.","volume":"218","author":"Lesses","year":"1938","journal-title":"N Engl J Med"},{"key":"R4-5-20210202","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1210\/endo-27-5-776","article-title":"The treatment of obesity due to dietary indiscretion (over-eating) with benzedrine sulfate.","volume":"27","author":"Ersner","year":"1940","journal-title":"Endocrinology"},{"key":"R5-5-20210202","first-page":"74","article-title":"The effect of amphetamine (Benzedrine) sulfate and thyroid hormone in the treatment of obesity: observations on 500 cases.","volume":"39","author":"Kalb","year":"1942","journal-title":"J Med Soc NJ"},{"key":"R6-5-20210202","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.1947.02880340022005","article-title":"The mechanism of amphetamine-induced loss of weight.","volume":"134","author":"Harris","year":"1947","journal-title":"J Am Med Assoc"},{"key":"R7-5-20210202","doi-asserted-by":"crossref","first-page":"983","DOI":"10.7326\/0003-4819-21-6-983","article-title":"The use of Benzedrine sulfate in obesity.","volume":"21","author":"Albrecht","year":"1944","journal-title":"Ann Intern Med"},{"key":"R8-5-20210202","first-page":"232","article-title":"A comparative trial of different regimens of fenfluramine and phentermine in obesity.","volume":"211","author":"Steel","year":"1973","journal-title":"The Practitioner"},{"key":"R9-5-20210202","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF00404223","article-title":"Locomotor activity and anorexigenic action.","volume":"14","author":"Rossum","year":"1969","journal-title":"Psychopharmacologia"},{"key":"R10-5-20210202","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00426841","article-title":"Comparison of behavior maintained by infusions of eight phenylethylamines in baboons.","volume":"50","author":"Griffiths","year":"1976","journal-title":"Psychopharmacology (Berl)"},{"key":"R11-5-20210202","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0022-3565(24)37989-3","article-title":"Effects of phentermine on responding maintained under multiple fixed-ratio schedules of food and cocaine presentation in the rhesus monkey.","volume":"288","author":"Wojnicki","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-5-20210202","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/00952997909007032","article-title":"Frequency of use or abuse of amphetamine-related drugs.","volume":"6","author":"Jain","year":"1979","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R13-5-20210202","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0306-4603(98)00011-2","article-title":"Reliability and validity of the Cocaine Selective Severity Assessment.","volume":"23","author":"Kampman","year":"1998","journal-title":"Addictive Behaviors"},{"key":"R15-5-20210202","first-page":"1320","article-title":"The nature, time course and severity of methamphetamine withdrawal. Addiction (Abingdon, England).","volume":"100","author":"McGregor","year":"2005","journal-title":""},{"key":"R16-5-20210202","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jsat.2007.05.007","article-title":"Psychometric evaluation of the Amphetamine Cessation Symptom Assessment.","volume":"34","author":"McGregor","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"R17-5-20210202","first-page":"S292","article-title":"A survey of prescribing practices of medical bariatricians.","volume":"16","author":"Hendricks","year":"2008","journal-title":"Obesity"},{"key":"R18-5-20210202","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/oby.2008.587","article-title":"Association between adult attention deficit\/hyperactivity disorder and obesity in the US population.","volume":"17","author":"Pagoto","year":"2009","journal-title":"Obesity"},{"key":"R19-5-20210202","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10550490600998476","article-title":"Outcome predictors in cocaine dependence treatment trials.","volume":"15","author":"Ahmadi","year":"2006","journal-title":"Am J Addict"},{"key":"R20-5-20210202","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/10550490701755999","article-title":"Cocaine withdrawal symptoms identify Type B cocaine-dependent patients.","volume":"17","author":"Ahmadi","year":"2008","journal-title":"Am J Addict"},{"key":"R21-5-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/10550490802545174","article-title":"Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment.","volume":"18","author":"Ahmadi","year":"2009","journal-title":"Am J Addict"},{"key":"R22-5-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jsat.2006.05.009","article-title":"Heroin and cocaine craving and use during treatment: measurement validation and potential relationships.","volume":"31","author":"Heinz","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"R23-5-20210202","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0376-8716(97)00111-7","article-title":"The applicability of the dependence syndrome to amphetamine.","volume":"48","author":"Topp","year":"1997","journal-title":"Drug Alcohol Depend"},{"key":"R25-5-20210202","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0022-3565(25)21295-2","article-title":"Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects.","volume":"279","author":"Evans","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"R26-5-20210202","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1176\/ajp.2006.163.12.2059","article-title":"Attention Deficit Hyperactivity Disorder and Substance Use Disorders.","volume":"163","author":"Wilens","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R27-5-20210202","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/archpedi.162.10.916","article-title":"Effect of prior stimulant treatment for attention-deficit\/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.","volume":"162","author":"Wilens","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R28-5-20210202","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1542\/peds.111.1.179","article-title":"Does stimulant therapy of attention-deficit\/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.","volume":"111","author":"Wilens","year":"2003","journal-title":"Pediatrics"},{"key":"R29-5-20210202","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/cap.2005.15.787","article-title":"The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit\/hyperactivity disorder: what does the literature tell us?","volume":"15","author":"Wilens","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R30-5-20210202","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/oby.2004.226","article-title":"The long-term management of obesity with continuing pharmacotherapy.","volume":"12","author":"Frank","year":"2004","journal-title":"Obes Res"},{"key":"R31-5-20210202","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1210\/edrv.20.6.0383","article-title":"Current and potential drugs for treatment of obesity.","volume":"20","author":"Bray","year":"1999","journal-title":"Endocr Rev"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e3181d070d7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:37:42Z","timestamp":1739986662000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201107000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181d070d7","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}